13F HOLDINGS REPORT
Opaleye Management Inc.
Quarter ended Q3 2023 · Filed August 14, 2023 · Accession 0001493152-23-028636
Total Value
$418.1M
Positions
47
Other Managers
0
Confidential Omitted
No
Holdings (47)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ACELYRIN INC | 00445A100 | 4,158,638 | $86.9M | 20.79% |
| 2 | HARROW HEALTH INC | HROW | 3,775,000 | $71.9M | 17.19% |
| 3 | OCULAR THERAPEUTIX INC | OCUL | 5,780,000 | $29.8M | 7.13% |
| 4 | TELA BIO INC | TELA | 1,580,000 | $16.0M | 3.83% |
| 5 | CRINETICS PHARMACEUTICALS INC | CRNX | 845,000 | $15.2M | 3.64% |
| 6 | KEROS THERAPEUTICS INC | KROS | 352,650 | $14.2M | 3.39% |
| 7 | BIOHAVEN LTD | BHVN | 540,000 | $12.9M | 3.09% |
| 8 | RHYTHM PHARMACEUTICALS INC | RYTM | 735,000 | $12.1M | 2.90% |
| 9 | IDEAYA BIOSCIENCES INC | IDYA | 415,000 | $9.8M | 2.33% |
| 10 | MORPHOSYS AG | 617760202 | 1,209,380 | $9.0M | 2.16% |
| 11 | VAXCYTE INC | PCVX | 177,000 | $8.8M | 2.11% |
| 12 | ETON PHARMACEUTICALS INC | ETON | 2,285,000 | $8.0M | 1.91% |
| 13 | GERON CORP | GERN | 2,350,000 | $7.5M | 1.80% |
| 14 | MARINUS PHARMACEUTICALS INC | 56854Q200 | 625,000 | $6.8M | 1.62% |
| 15 | KALVISTA PHARMACEUTICALS INC | KALV | 720,000 | $6.5M | 1.55% |
| 16 | PROTARA THERAPEUTICS INC | TARA | 2,692,594 | $6.4M | 1.54% |
| 17 | EDGEWISE THERAPEUTICS INC | EWTX | 815,000 | $6.3M | 1.51% |
| 18 | CYMABAY THERAPEUTICS INC | 23257D103 | 566,700 | $6.2M | 1.48% |
| 19 | UROGEN PHARMA LTD | URGN | 570,000 | $5.9M | 1.41% |
| 20 | THERAVANCE BIOPHARMA INC | TBPH | 543,500 | $5.6M | 1.35% |
| 21 | THESEUS PHARMACEUTICALS INC | 88369M101 | 597,500 | $5.6M | 1.33% |
| 22 | ACADIA PHARMACEUTICALS INC | ACAD | 217,000 | $5.2M | 1.24% |
| 23 | INTELLIA THERAPEUTICS INC | NTLA | 120,000 | $4.9M | 1.17% |
| 24 | LIQUIDIA CORPORATION | LQDA | 570,700 | $4.5M | 1.07% |
| 25 | LARIMAR THERAPEUTICS INC | LRMR | 1,390,000 | $4.4M | 1.04% |
| 26 | CYTOKINETICS INC | CYTK | 130,000 | $4.2M | 1.01% |
| 27 | TREVI THERAPEUTICS INC | TRVI | 1,701,500 | $4.1M | 0.97% |
| 28 | GOSSAMER BIO INC | GOSS | 3,370,000 | $4.0M | 0.97% |
| 29 | 4D MOLECULAR THERAPEUTICS INC | FDMT | 221,700 | $4.0M | 0.96% |
| 30 | NYXOAH S A | NYXH | 445,000 | $3.6M | 0.85% |
| 31 | EDAP TMS S A | EDAP | 380,000 | $3.5M | 0.84% |
| 32 | KARYOPHARM THERAPEUTICS INC | KPTI | 1,785,000 | $3.2M | 0.76% |
| 33 | IOVANCE BIOTHERAPEUTICS INC | IOVA | 421,000 | $3.0M | 0.71% |
| 34 | SPECTRUM PHARMACEUTICALS | STXS | 3,074,995 | $3.0M | 0.71% |
| 35 | ASTRIA THERAPEUTICS INC | 04635X102 | 305,000 | $2.5M | 0.61% |
| 36 | CODEXIS INC | CDXS | 675,000 | $1.9M | 0.45% |
| 37 | FORTRESS BIOTECH INC | FBIOP | 3,310,000 | $1.8M | 0.44% |
| 38 | SUTRO BIOPHARMA INC | STRO | 307,000 | $1.4M | 0.34% |
| 39 | BLACK DIAMOND THERAPEUTICS | BDTX | 275,000 | $1.4M | 0.33% |
| 40 | TRACON PHARMACEUTICALS INC | 89237H209 | 4,764,508 | $1.4M | 0.33% |
| 41 | PROQR THERAPEUTICS NV | N71542109 | 653,000 | $1.1M | 0.25% |
| 42 | JASPER | 481116101 | 669,944 | $917,823 | 0.22% |
| 43 | VERASTEM INC | VSTM | 102,000 | $758,880 | 0.18% |
| 44 | XOMA CORP DEL | XOMAP | 275,000 | $594,750 | 0.14% |
| 45 | IGM BIOSCIIENCES INC | 449585108 | 63,500 | $586,105 | 0.14% |
| 46 | FULCRUM THERAPEUTICS INC | FULC | 143,600 | $473,880 | 0.11% |
| 47 | KEZAR LIFE SCIENCES INC | KZR | 98,796 | $242,050 | 0.06% |